In a recent clinical study (NCT02097277) of pegbelfermin (BMS-986036, polyethylene glycol-attached, PEGylated FGF21), however, little effect on Hb1Ac or body weight was observed in obese patients with type 2 diabetes [82]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.